Sonida Senior Living, Inc. (SNDA)
NYSEHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
$37.69-0.50%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
QuarterlyIQ Insights · SNDA
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Focus on integrating the CNL Healthcare Properties acquisition and achieving anticipated benefits including NOI growth and margin expansion.
Stated as a priority in 2 of last 2 quarters. The CHP acquisition closed in 2026-Q1, driving a 36.7% increase in resident revenue and 14% NOI growth pro forma. In 2026-Q2, Same-Store NOI grew 16.9% with occupancy up 240 bps to 87.8%. Management is delivering on integration and value realization.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Health Care names rated strong grew net income 53% of the time over the next year (vs 41% for the rest of the cohort, n=9986).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“Primary objective continues to be driving sustained strong NOI growth in the existing portfolio.”
“Completed acquisition of CHP and delivered strong pro forma results with occupancy up 220 bps and NOI up 14%.”
Maintain disciplined capital allocation with equity offerings, debt refinancing, and balance sheet flexibility to support growth and liquidity.
Stated as a priority in 2 of last 2 quarters. Management refinanced debt with a $380 million term loan in 2026-Q2, repaying prior term and bridge loans and reducing revolving credit by $70 million. The ATM equity program raised $27.3 million net proceeds. The trajectory shows active capital management supporting liquidity and growth.
“Entered into $380 million term loan, repaid $122 million term loan and $170 million bridge debt, paid down $70 million on revolving credit facility.”
“Completed bridge loan and term loan financing to fund CHP acquisition and repay debt; increased revolving credit facility commitment.”
Appoint new Chief Operating Officer to enhance operational performance, scale platform, and drive margin expansion.
Newly stated in 2026-Q2. The appointment of Anton Nikodemus as COO in June 2026 aims to strengthen operations and drive margin expansion. This is a strategic leadership transition with no direct financial metrics yet available to assess delivery.
“Anton Nikodemus appointed COO to accelerate scalability, elevate resident experience, and support growth.”
Over the trailing year it converted 0.87x of net income into operating cash flow.
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity (low R² over the window).
32 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Health Care names rated volatile grew net income 53% of the time over the next year (vs 50% for the rest of the cohort, n=3986).
Not investment advice. As of 2026-09-04.